Immune checkpoint gene VSIR predicts patient prognosis in acute myeloid leukemia and myelodysplastic syndromes

BACKGROUND: Immune checkpoint proteins play critical functions during the immune response to cancer and have been targeted by immune checkpoint blockade therapy. V‐domain Ig suppressor of T cell activation (VSIR) is one of these immune checkpoint genes and has been investigated extensively in recent...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Kevin, Zhou, Emily, Schaafsma, Evelien, Zhang, Baoyi, Cheng, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028170/
https://www.ncbi.nlm.nih.gov/pubmed/36394080
http://dx.doi.org/10.1002/cam4.5409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028170/
https://www.ncbi.nlm.nih.gov/pubmed/36394080
http://dx.doi.org/10.1002/cam4.5409

Ejemplares similares